BEAM
Price
$21.66
Change
-$0.21 (-0.96%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
2.2B
109 days until earnings call
Intraday BUY SELL Signals
EYPT
Price
$11.51
Change
-$0.48 (-4.00%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
993.45M
112 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs EYPT

Header iconBEAM vs EYPT Comparison
Open Charts BEAM vs EYPTBanner chart's image
Beam Therapeutics
Price$21.66
Change-$0.21 (-0.96%)
Volume$108.35K
Capitalization2.2B
EyePoint Pharmaceuticals
Price$11.51
Change-$0.48 (-4.00%)
Volume$47.17K
Capitalization993.45M
BEAM vs EYPT Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. EYPT commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and EYPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BEAM: $21.87 vs. EYPT: $11.99)
Brand notoriety: BEAM and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 71% vs. EYPT: 94%
Market capitalization -- BEAM: $2.2B vs. EYPT: $952.88M
BEAM [@Biotechnology] is valued at $2.2B. EYPT’s [@Biotechnology] market capitalization is $952.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while EYPT’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 7 bearish.
  • EYPT’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than EYPT.

Price Growth

BEAM (@Biotechnology) experienced а -5.20% price change this week, while EYPT (@Biotechnology) price change was +8.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

EYPT is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.2B) has a higher market cap than EYPT($993M). EYPT YTD gains are higher at: 60.940 vs. BEAM (-11.815). EYPT has higher annual earnings (EBITDA): -172.05M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. EYPT (256M). EYPT has less debt than BEAM: EYPT (21.8M) vs BEAM (155M). BEAM has higher revenues than EYPT: BEAM (60.3M) vs EYPT (51.9M).
BEAMEYPTBEAM / EYPT
Capitalization2.2B993M221%
EBITDA-414.33M-172.05M241%
Gain YTD-11.81560.940-19%
P/E RatioN/AN/A-
Revenue60.3M51.9M116%
Total Cash1.15B256M449%
Total Debt155M21.8M711%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
14
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMEYPT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
EYPT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WCMWX19.770.09
+0.46%
WCM Focused Emerging Mkts Ex Chn Inst
NSRKX27.310.10
+0.37%
Northern World Selection Index K
DCUSX15.460.04
+0.26%
DWS CROCI US S
ARIGX18.18-0.05
-0.27%
Aristotle Growth Equity I
LGLVX60.07-0.24
-0.40%
Lord Abbett Growth Leaders R6

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with LYRA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+2.96%
LYRA - EYPT
58%
Loosely correlated
-8.49%
OCUL - EYPT
55%
Loosely correlated
+2.41%
ATHE - EYPT
54%
Loosely correlated
+3.27%
ERAS - EYPT
52%
Loosely correlated
+12.29%
BEAM - EYPT
48%
Loosely correlated
-2.71%
More